View source for Singlefraction HDR brachytherapy as monotherapy within reduced and more advanced risk cancer of prostate Benefits through two clinical trials together with as well as lacking an MRIguided enhance
From EECH Central
You do not have permission to edit this page, for the following reasons:
You can view and copy the source of this page.